|Year : 2020 | Volume
| Issue : 4 | Page : 620-626
Comparison of the corrected intraocular pressure by tonopachy with that of Goldmann applanation tonometry in normal and glaucomatous patients
Girish Velis1, Srinivasan Kavitha1, Nazlee Zebardast2, Sabyasachi Sengupta1, Rengaraj Venkatesh1
1 Department of Glaucoma, Aravind Eye Hospital, Pondicherry, India
2 Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA
|Date of Submission||25-Mar-2019|
|Date of Acceptance||26-Oct-2019|
|Date of Web Publication||16-Mar-2020|
Dr. Srinivasan Kavitha
Aravind Eye Hospital, Cuddalore Main Road, Thavalakuppam - 605 007, Pondicherry
Source of Support: None, Conflict of Interest: None
Purpose: To compare corrected intraocular pressure (IOP) by tonopachy with that of Goldmann applanation tonometry (GAT) in normal and glaucomatous patients. Methods: In this cross-sectional study, IOP and central corneal thickness (CCT) were measured in 426 eyes (213 normal eyes and 213 glaucomatous eyes) of 426 patients by tonopachy followed by GAT and ultrasound pachymetry. IOP was corrected for CCT by in-built formula in tonopachy and Ehlers correction factor for Goldmann tonometer. Limits of agreements were assessed using Bland–Altman plots. Intraclass correlation coefficient was calculated to estimate the absolute agreement between single and average measurements of IOP and CCT of tonopachy with that of Goldmann tonometer and ultrasound pachymetry respectively. Results: Mean corrected IOP measured with tonopachy and GAT in glaucomatous eyes was 17.63 ± 5.04 mmHg and 19.42 ± 5.83 mmHg, and in controls it was 13.4 ± 2.5 mmHg and 16.2 ± 3.1 mmHg, respectively. Limits of agreement ranged from –4.63 to +9.25 mmHg for total population (mean = 2.31), —6.01 to +9.59 mmHg (mean = 1.79) for glaucoma group and —2.99 to +8.65 mmHg (mean = 2.83) for controls. Intraclass correlation coefficient for IOP measurement between tonopachy and Goldmann tonometer was 0.84 for total population, 0.85 for glaucoma group, and 0.63 for controls, respectively. Conclusion: Corrected IOP obtained by tonopachy showed moderate agreement with GAT and it is more in glaucoma patients than controls. Thus, tonopachy can be used as a screening tool, but cannot replace GAT.
Keywords: Agreement, central corneal thickness, Goldmann applanation tonometer, intraocular pressure, tonopachy
|How to cite this article:|
Velis G, Kavitha S, Zebardast N, Sengupta S, Venkatesh R. Comparison of the corrected intraocular pressure by tonopachy with that of Goldmann applanation tonometry in normal and glaucomatous patients. Indian J Ophthalmol 2020;68:620-6
|How to cite this URL:|
Velis G, Kavitha S, Zebardast N, Sengupta S, Venkatesh R. Comparison of the corrected intraocular pressure by tonopachy with that of Goldmann applanation tonometry in normal and glaucomatous patients. Indian J Ophthalmol [serial online] 2020 [cited 2020 Apr 4];68:620-6. Available from: http://www.ijo.in/text.asp?2020/68/4/620/280690
Intraocular pressure (IOP) is the only modifiable risk factor in the treatment of glaucoma. Early successful treatment of elevated IOP can prevent optic nerve damage and blindness. Goldmann applanation tonometer (GAT), based on the Imbert-Fick law, is considered the clinical gold standard for IOP measurement.,,,, Most of our current understanding of the treatment of glaucoma is based on GAT readings.
Applanation tonometry is a contact procedure. It requires topical anesthesia and fluorescein staining and has certain limitations to its use, like need for technical expertise and it is a time-consuming procedure. Also as an indirect measure of the IOP, GAT outputs can be affected by the central corneal thickness (CCT) and other biomechanical properties of cornea. A thin or thick cornea can underestimate or overestimate IOP., Accordingly, there is a need to adjust IOP values taking CCT into consideration, for it may change the treatment decisions and affect patient outcomes., Several nomograms have been developed for adjusting GAT readings for varying CCT; however, these nomograms are not consistently accurate.,, It is expected that IOP is affected by CCT, but the exact numerical correction factor to account for CCT is uncertain.
There is a need to develop and introduce different instruments to measure IOP. In recent years, various devices have been designed with the intention of being minimally influenced by the individual eye characteristics and to provide non-contact IOP assessment. Each method, however, has been shown to have its own technical limitations like the need for longer applanation period for dynamic contour tonometry, etc. Since the introduction of non-contact tonometry (NCT), IOP can be measured without the use of anesthesia. The NCT is a simple and objective method of IOP measurement which can be performed by ancillary staff and hence employed as a screening tool.
A newly developed non-contact tono-pachymeter: Tonopachy™ (NT-530P, NIDEK Co., LTD, Gamagori, Japan) is a unique system that has two simultaneous functions, one is as a NCT for the measurement of IOP which can reduce the possible risk of transmission of infectious diseases, and the other is as a non-contact pachymeter for measuring CCT.,, The principle of IOP measurement by tonopachy is based on the ejection of an air pulse to the corneal surface similar to NCT and the measurement of CCT is based on the principle of the Scheimpflug camera.,,, Thus, it measures the IOP and CCT in a single shot without topical anesthesia. It can also calculate the corrected IOP with an in-built formula that uses the measurement data of CCT. These measurements are operator independent due to the auto-alignment function of the instrument. The automatic shut-off mechanism minimizes the subject's discomfort. It is thus expected to offer a simple, time saving and useful method for the simultaneous assessment of IOP and CCT for glaucomatous screening.
When a new instrument becomes available, it is important to compare its accuracy to that of a well-established method and to assess repeatability of its measurements. Few studies,,, have compared the efficacy of the tonopachy and GAT. These studies have been conducted in small samples and have been performed on healthy eyes with a normal IOP range. To our knowledge, the efficacy of tonopachy has not yet been studied in glaucomatous population. Thus, this study was undertaken in order to evaluate the efficacy of tonopachy in a wider range of IOP including glaucomatous eyes and to assess its level of agreement with the known gold standard of IOP and CCT measurement, that is, GAT and ultrasound pachymetry respectively. If proven useful, tonopachy can be considered for screening IOP and CCT in a high volume set up.
| Methods|| |
This study was approved by the Institutional Review board as well as the Ethical committee and followed the tenets of the Declaration of Helsinki.
Written informed consent was obtained from all the patients after explanation of the study's purpose, methods, and expected outcomes. Patients were also assured that their refusal to take part in the study would not compromise their treatment.
Study participants consisted of patients visiting the glaucoma services and normal individuals (without ophthalmic disease except for refractive error ± 3D spherical/cylindrical error and presbyopia) presenting to the general ophthalmology services at a tertiary eye hospital in south India over a period of 10 months from March 2013 to January 2014.
Glaucoma group consisted of newly diagnosed patients of primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG), and pseudoexfoliation glaucoma (PXFG). Patients were excluded if (1) diagnosed as glaucoma suspects, ocular hypertensives (OHT), normal tension glaucoma (NTG), secondary glaucomas (except for PXFG), primary angle closure (PAC), and primary angle closure suspects (PACS); (2) refractive error of more than ± 6D sphere and astigmatism of more than 3D; (3) history of contact lens use in the preceding week or any ocular surgery; (4) corneal pathology; (4) ocular comorbidities other than glaucoma; (5) unable to cooperate; and (6) monocular.
POAG was defined as IOP ≥22 mmHg, open angles on gonioscopy along with glaucomatous disc changes (cup disc ratio ≥0.6, notch, thinning of neuroretinal rim). PACG was defined as IOP ≥22 mmHg, closed angles on gonioscopy (trabecular meshwork could not be visualized for 180° or more) along with glaucomatous disc changes. Presence of pseudoexfoliation (PXF), IOP ≥22 mmHg, open or closed angles on gonioscopy along with glaucomatous disc changes constituted PXF glaucoma.
Once the patient qualified for inclusion in the study (after screening by GV), the detailed assessment of all study participants was done at glaucoma services prior to administration of mydriatic eye drops. It consisted of measurement of best corrected Snellen's distant visual acuity by trained technicians. After tonopachy evaluation, one of the investigators (SK, RV) did the slit-lamp biomicroscopic evaluation of the anterior segment, undilated evaluation of the optic disc using slit lamp and 90 dioptre lens, applanation tonometry, gonioscopy examination with the Goldmann 2 mirror goniolens followed by dilated fundus evaluation using 90 dioptre lens. On the day of recruitment, each study participant underwent the following tests, in the following order:
Tonopachy™ (NT-530P; Nidek Co., LTD, Gamagori, Japan) readings
: A single trained technician with experience in using the tonopachy instrument measured IOP and CCT. Patient was asked to keep the forehead against the forehead rest and look at the fixation target. Three CCT and three IOP readings were obtained and the instrument automatically averaged each of the three CCT and three IOP readings. The IOP reading thus obtained was corrected automatically by an algorithm in built in the tonopachy.
GAT (AT-900; Haag–Streit International, Koeniz, Switzerland) readings
: Two IOP readings were obtained before pupillary dilation by one of the study investigators (SK, RV) using the slit-lamp mounted GAT in a masked manner. 0.5% Proparacaine was used as the topical anesthetic and the eye was stained with sterile wetted fluorescein strip. A magnification of 10× on the slit lamp was used with cobalt blue filter to detect end points. A technician set the drum dial to an arbitrary number between 5 and 25 mmHg. The study investigator (SK, RV) applanated by applying varying amounts of mechanical pressure to obtain the end point and result was recorded by the technician. Average of the two IOP readings was considered and it was corrected for CCT as per the corrections suggested by Ehlers et al.
Ultrasound pachymetry (300P Pacscan, Sonomed Escalon) readings
: Patient was asked to fixate on a target. Following instillation of the topical anesthetic 0.5% Proparacaine, the pachymeter probe was gently aligned as perpendicularly as possible to the central cornea. Five CCT readings were obtained by the study investigator (SK, RV) and the automatically generated average value displayed on the screen was used as CCT. If the standard deviation of CCT was >10 μm, all measurements were repeated.
In accordance with the previous studies, the non-contact method tonopachy was performed first followed by GAT after 10 min interval. This order was followed to avoid possible reduction in IOP as a result of forced aqueous massage during the process of indentation with GAT. Both, the ophthalmic technician performing tonopachy and the study investigators performing the GAT and ultrasound pachymetry were masked to readings by the other instrument as well as the glaucoma status of the patient. All the IOP and CCT readings by tonopachy were recorded by the same ophthalmic technician. Similarly, the same study investigators measured the IOP by GAT and CCT by ultrasound pachymetry to avoid inter-observer bias. All measurements were done during office hours only. All the instruments used in the study were calibrated once in 2 weeks prior to data collection.
Using a pilot sample of 30 subjects, a sample size of 426 subjects (213 normal and 213 glaucomatous subjects) was selected to allow for standard deviation (SD) of 7.2 in the glaucoma group and 6.8 in the control group with a mean difference of 1.9 between the two groups, based on type I error probability of 0.05 and a power of 0.8.
Four hundred twenty-six eyes of 426 patients, consisting of 213 eyes as controls and 213 glaucomatous eyes were analyzed in the study. The right eyes of the study participants in both the groups were analyzed.
Uncorrected IOP obtained by the two devices was compared first followed by comparison of CCT corrected IOP. Descriptive statistics were used to report demographic characteristics. Chi-square test was used for categorical variables to evaluate group differences. Bland–Altman plots were used to assess the limits of agreements (LoA) and their 95% confidence interval between tonopachy and GAT measurements of IOP, and between CCT measurements obtained with the tonopachy and ultrasound pachymetry. The intraclass correlation coefficient (ICC) was calculated in order to estimate the absolute agreement between single and average measurements of IOP and CCT taken with the tonopachy and the GAT and ultrasound pachymetry respectively. The difference between corrected IOP measurements using the GAT and tonopachy (DIOP) for each eye was calculated and factors predicting DIOP were assessed using multivariable linear regression analysis adjusted for age and gender. Baseline IOP and glaucoma diagnosis were not included due to likely significant collinearity. P <0.05 was considered statistically significant. All analysis was conducted using STATA version 11.1 (StataCorp, College Station, TX).
| Results|| |
Patients with glaucoma were significantly older (58.7 ± 10.9 years) than controls (49.5 ± 8.7 years) (P < 0.001). There was no significant difference in the gender distribution between the groups (P = 0.327; [Table 1]). Out of 213 glaucomatous eyes: 140 (65.73%) were POAG, 40 were (18.78%) PACG, and 33 (15.49%) were PXFG.
The mean uncorrected IOP for the total population measured with the tonopachy and GAT was 15.09 ± 4.42 mmHg [Range (R) = 10–35 mmHg] and 16.64 ± 4.80 mmHg (R = 10–36 mmHg), respectively.
In controls, the mean uncorrected IOP measured with the tonopachy was 12.93 ± 1.89 mmHg (R = 10–20 mmHg) as compared to 14.92 ± 2.79 mmHg (R = 10–24 mmHg) with GAT (P < 0.001: [Table 2]). In the glaucoma group, the mean uncorrected IOP with the tonopachy was 17.25 ± 5.13 mmHg (R = 10–35 mmHg) as compared to 18.35 ± 5.71 mmHg (R = 10–36 mmHg) with GAT (P < 0.001; [Table 2]).
The CCT corrected IOP was 15.51 ± 4.52 mmHg (R = 6.42–39.02 mmHg) and 17.82 ± 4.94 mmHg (R = 10–39 mmHg) with tonopachy and GAT respectively for the total population (P < 0.001; [Table 3]). In the control group, the mean corrected IOP measured with the tonopachy was 13.4 ± 2.5 mmHg (R = 6.42–22.36 mmHg) compared to 16.22 ± 3.13 mmHg (R = 10–24 mmHg) with GAT (P < 0.001; [Table 3]). In the glaucoma group, the mean corrected IOP measured with the tonopachy was 17.63 ± 5.04 mmHg (R = 7.78–39.02 mmHg) as compared to 19.42 ± 5.83 mmHg (R = 10–40 mmHg) with GAT respectively (P < 0.001; [Table 3]).
Tonopachy underestimated corrected IOP compared to GAT in both the controls and glaucoma patients by about 2 mmHg and the difference was statistically significant (P < 0.001). Also there was statistically significant difference between the IOP readings obtained in the glaucoma group and controls (P < 0.001; Independent t-test).
The Bland–Altman plot analysis for corrected IOP showed that the mean IOP difference was 2.31 and the 95% limits of agreement ranged from –4.63 to +9.25 mmHg for the total population, -—6.01 to +9.59 mmHg (mean = 1.79) for the glaucoma group and -2.99 to +8.65 mmHg (mean = 2.83) for the normal group [Figure 1], [Figure 2], [Figure 3]. The LOWESS curve was smoother for all the groups [Figure 4, [Figure 5], [Figure 6]. The Intraclass correlation (ICC) for IOP measurement between tonopachy and GAT was 0.84 for the total population, 0.85 for the glaucoma group, and 0.63 for the normal group, respectively. ICC shows that these two methods of IOP measurement correlate but the Bland–Altmann plot indicate that they have moderate agreement. In 64.5% (275) of the eyes studied, the mean IOP difference between tonopachy and GAT was less than 3 mmHg [Table 4]. After correcting for age, DIOP was significantly greater with higher baseline GAT IOP (2.08 mmHg increase with every 5 mmHg increase in baseline GAT IOP) and higher in study participants with glaucoma compared to controls (DIOP = 2.59 mmHg higher in glaucoma subjects) [Table 5]. There was a significant difference between the uncorrected and corrected IOP by both tonopachy and GAT (P < 0.05 for all; [Table 6] and [Table 7]).
|Table 5: Multivariable linear regression analysis to detect factors influencing ΔIOP (GAT-Tonopachy)|
Click here to view
|Figure 4: LOWESS curve for corrected IOP by Tonopachy VS GAT for overall patients|
Click here to view
|Figure 5: LOWESS curve for corrected IOP by Tonopachy VS GAT in glaucoma patients|
Click here to view
|Figure 6: LOWESS curve for corrected IOP by Tonopachy VS GAT in controls|
Click here to view
The mean CCT measured with the tonopachy and ultrasound pachymetry for the total population was 533.54 ± 35.70 μm and 528.63 ± 34.42 μm, respectively, for the glaucoma group, was 534.51 ± 36.26 μm and 530.09 ± 34.38 μm, respectively, and for the controls, was 532.58 ± 35.19 μm and 527.16 ± 34.49 μm, respectively [Table 8]. Tonopachy marginally overestimated CCT compared to ultrasound pachymetry and the difference was statistically significant [P < 0.001 for the total and normal population and P < 0.0001 for the glaucoma group]. The ICC for CCT by tonopachy and ultrasound pachymetry was 0.94 for the total population and the glaucoma group and 0.93 for the normal group, respectively.
| Discussion|| |
In our study, tonopachy consistently reported lower corrected IOP compared to the gold standard, that is, GAT, in eyes with and without glaucoma. The magnitude of underestimation was almost identical at 2 mmHg in both the glaucoma and control groups. Additionally, we found that tonopachy marginally overestimated CCT in eyes with and without glaucoma. In contrast to our findings, Lee et al., Garcia-Resua and Pena-Verdeal et al. and Domenico Schiano et al. found that tonopachy overestimated the IOP compared to GAT. This discrepancy in the observation could be due to the fact that all these studies were performed in healthy eyes with a normal IOP range, and in these studies CCT corrected IOP was not taken into consideration. This could also be due to the overestimation of CCT by tonopachy as in our study.
Tonopachy adapts the IOP measurement method used in NCT. In most studies, comparisons with GAT indicate that the NCT is reliable within the normal IOP range, although the reliability is reduced in the higher pressure ranges.,,,, Lee et al. observed that differences in IOP measurements between tonopachy and GAT increased with increasing IOP. Even we noticed that higher the baseline IOP, the DIOP was high between the two instruments.
It appears from the data that there is a moderate agreement between the corrected IOP provided by the tonopachy and one obtained using GAT and this agreement is less in glaucoma patients compared to controls. Additionally, the agreement seems to be reducing with progressively increasing baseline IOP measurements. Garcia-Resua and Pena-Verdeal et al. and Domenico Schiano et al. reported moderate agreement between the pressure readings provided by the tonopachy and those offered by the GAT. Lee et al. reported good agreement in IOP measurements by tonopachy and GAT. But the limits of agreement between the tonopachy and GAT (95% LoA: -2.3 to 4.7 mm Hg) in his study were slightly larger than those from other studies, which have made similar comparisons between NCT and GAT (95% LoA ranged from - 3.14 to 2.74 mm Hg).
Garcia-Resua and Pena-Verdeal et al. detected no correlation between CCT and Tonopachy-C IOP (CCT corrected IOP), indicating no significant effect of CCT on tonopachy-C IOP measurements. However, their study involved relatively normal/restricted range of corneal thickness. In our study, both the uncorrected and corrected IOP by tonopachy were consistently lower than the respective uncorrected and corrected IOP by GAT. Also there was a significant difference between the uncorrected and corrected IOP by tonopachy and GAT, indicating that they are not interchangeable.
In our study, the mean IOP difference between tonopachy and GAT was <3 mmHg in 64.5% of the eyes. This finding was somewhat lower than found by others. Rampersad et al. reported that in 79.1% of measurements, the IOP differed by less than 3 mmHg between the tonopachy and GAT. Garcia-Resua and Pena-Verdeal et al. found approximately 88% of the IOP differences between the Goldmann and Tonopachy-NC and 86% of the differences between the Goldmann and Tonopachy-C within 3.0 mmHg. Our results show that the possibility of incurring a clinically significant error when measuring IOP is about one in every third eye examined when using the tonopachy compared with GAT.
Also, regression analysis shows that there is a statistically significant difference between the Δ IOP (difference between the corrected IOP obtained using the Tonopachy and GAT) in control group compared to glaucoma patients, with greater difference in glaucomatous eyes. This suggests that tonopachy may offer less accurate results in glaucomatous eyes than healthy eyes. This is problematic, as greater accuracy is needed in this population. Also, tonopachy underestimates the IOP and its accuracy decreases at higher IOPs which can create issues in glaucoma screening.
Large sample size with a control group, masking the observers to the IOP readings, calculation of CCT corrected as well as uncorrected IOP are the advantages of the study. This study is also unique in that the device is assessed in glaucoma patients at higher ranges of IOP and wider range of CCT. The study is limited by the fact that glaucoma group included predominantly primary glaucomas, secondary glaucomas (except PXFG) were not included. Also present study consisted of south Indian cohort, so the results may not be generalized to the other population. Although the IOP and CCT readings obtained by tonopachy are comparable with that obtained by GAT and ultrasound pachymetry, careful attention should be paid while interpreting the corrected IOP, as the values may not be totally interchangeable. There is statistically significant difference in the efficacy of tonopachy in patients with and without glaucoma.
| Conclusion|| |
In conclusion, tonopachy has acceptable agreement compared to GAT, with an advantage of measuring both the IOP and CCT by non-contact method in a single shot without significant expertise. Hence it can be employed as a screening tool for IOP testing in a high volume clinical set up. However, it cannot replace the existing gold standard method for IOP measurement, the GAT.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: A review. JAMA 2014;311:1901-11.
Tuulonen A, Airaksinen PJ, Erola E, Forsman E, Friberg K, Kaila M, et al.
The Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol Scand 2003;81:3-18.
Beatty S, Nischal KK, Jones H, Eagling EM. Effect of applanation tonometry on mean corneal curvature. J Cataract Refract Surg 1996;22:970-1.
Cho P, Lui T. Comparison of the performance of the Nidek NT-2000 non-contact tonometer with the Keeler Pulsair 2000 and the Goldmann applanation tonometer. Optom Vis Sci 1997;74:51-8.
Hansen MK. Clinical comparison of the XPERT non-contact tonometer and the conventional Goldmann applanation tonometer. Acta Ophthalmol Scand 1995;73:176-80.
Jorge J, Diaz-Rey JA, Gonzalez-Meijome JM, Almeida JB, Parafita MA. Clinical performance of the Reichert AT550: A new non-contact tonometer. Ophthalmic Physiol Opt 2002;22:560-4.
Van der Jagt LH, Jansonius NM. Three portable tonometers, the TGDc-01, the ICARE and the Tonopen XL, compared with each other and with Goldmann applanation tonometry. Ophthalmic Physiol Opt 2005;25:429-35.
Whitacre MM, Stein R. Sources of error with use of Goldmann-type tonometers. Surv Ophthalmol 1993;38:1-30.
Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measurements: A review and meta analysis approach. Surv Ophthalmol 2000;44:367-408.
Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol 1997;115:1137-41.
Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al.
The ocular hypertension treatment study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20.
Gunvant P, O'Leary DJ, Baskaran M, Broadway DC, Watkins RJ, Vijaya L. Evaluation of tonometric correction factors. J Glaucoma 2005;14:337-43.
Feltgen N, Leifert D, Funk J. Correlation between central corneal thickness, applanation tonometry, and direct intracameral IOP readings. Br J Ophthalmol 2001;85:85-7.
Kirstein EM, Husler A. Evaluation of the Orssengo-Pye IOP corrective algorithm in LASIK patients with thick corneas. Optometry 2005;76:536-43.
Lee GA, Khaw PT, Ficker LA, Shah P. The corneal thickness and intraocular pressure story: Where are we now? Clin Exp Ophthalmol2002;30:334-7.
Mollan SP, Wolffsohn JS, Nessim M, Laiquzzaman M, Sivakumar S, Hartley S, et al.
Accuracy of Goldmann, ocular response analyser, Pascal and TonoPen XL tonometry in keratoconic and normal eyes. Br J Ophthalmol 2008;92:1661-5.
Shields MB. The non-contact tonometer. Its value and limitations. Surv Ophthalmol1980;24:211-9.
Lee YG, Kim JH, Kim NR, Kim CY, Lee ES. Comparison between Tonopachy and other tonometric and pachymetric devices. Optom Vis Sci 2011;88:843-9.
Garcia-Resua C, Pena-Verdeal H, Minones M, Giraldez MJ, Yebra-Pimentel E. Reliability of the non-contact tono-pachymeter Tonopachy NT-530P in healthy eyes. Clin Exp Optom 2013;96:286-94.
Schiano Lomoriello D, Lombardo M, Tranchina L, Oddone F, Serrao S, Ducoli P. Repeatability of intra-ocular pressure and central corneal thickness measurements provided by a non-contact method of tonometry and pachymetry. Graefe's Arch Clin Exp Ophthalmol 2011;249:429-34.
O'Donnell C, Maldonado-Codina C. Agreement and repeatability of central thickness measurement in normal corneas using ultrasound pachymetry and the OCULUS Pentacam. Cornea2005;24:920-4.
Lackner B, Schmidinger G, Pieh S, Funovics MA, Skorpik C. Repeatability and reproducibility of central corneal thickness measurement with Pentacam, Orbscan, and ultrasound. Optom Vis Sci 2005;82:892-9.
Barkana Y, Gerber Y, Elbaz U, Schwartz S, Ken-Dror G, Avni I, et al.
Central corneal thickness measurement with the Pentacam Scheimpflug system, optical low-coherence reflectometry pachymeter, and ultrasound pachymetry. J Cataract Refract Surg 2005;31:1729-35.
Ucakhan OO, Ozkan M, Kanpolat A. Corneal thickness measurements in normal and keratoconic eyes: Pentacam comprehensive eye scanner versus noncontact specular microscopy and ultrasound pachymetry. J Cataract Refract Surg 2006;32:970-7.
Garcia-Resua C, Blanco A, Minones M, Yebra-Pimentel E, Jesus Giraldez M. Accuracy and repeatability of a new tono-pachymeter for measuring central corneal thickness. Eye Contact Lens 2012;38:158-63.
Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol (Copenh) 1975;53:34-43.
Almubrad TM, Ogbuehi KC. On repeated corneal applanation with Goldmann and two non-contact tonometers. Clin Exp Optom 2010;93:77-82.
Popovich KS, Shields MB. A comparison of intraocular pressure measurements with the XPERT noncontact tonometer and Goldmann applanation tonometry. J Glaucoma 1997;6:44–6.
Babalola OE, Kehinde AV, Iloegbunam AC, Akinbinu T, Moghalu C, Onuoha I. A comparison of the Goldmann applanation and noncontact (Keeler Pulsair EasyEye) tonometers and the effect of central corneal thickness in indigenous African eyes. Ophthalmic Physiol Opt 2009;29:182-8.
Jorge J, Fernandes P, Queiros A, Ribeiro P, Garces C, Gonzalez- Meijome JM. Comparison of the IOPen and iCare rebound tonometers with the Goldmann tonometer in a normal population. Ophthalmic Physiol Opt 2010;30:108-12.
Carrim ZI, Lavy TE. Goldmann tonometry versus the Tono-Pen XL for intraocular pressure measurement: An evaluation of the potential impact on clinical decision making in glaucoma. Ophthalmic Physiol Opt 2009;29:648-51.
Rampersad N, Mashige KP, Jhetam S. A comparison of intraocular pressure values obtained with the Tono-Pachymeter NT530P, iCare® rebound tonometer and Goldmann applanation tonometer. S Afr Optom 2011:70;109-16.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8]